MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Gender differences of fatigue characteristics in people with Parkinson’s disease

    G. Cilga, T. Kahraman, AC. Kalkan, B. Donmez Colakoglu, A. Genc (Manisa, Turkey)

    Objective: To investigate gender differences in fatigue characteristics in people with Parkinson’s disease. Background: Fatigue is a common problem among people with Parkinson’s disease. It…
  • 2019 International Congress

    Language disorders in Progressive Supranuclear Palsy: an underestimated condition?

    E. Del Prete, L. Tommasini, D. Frosini, S. Mazzucchi, C. Pagni, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

    Objective: We aimed to investigate executive functions and languages abilities in PSP patients and in Progressive Supranuclear Palsy (PSP) subgroups [PSP-Richardson’s Syndrome (PSP-RS) and PSP-non-RS]…
  • 2019 International Congress

    Levodopa response in later stages of Parkinson’s disease: a case-control study

    M. Fabbri, M. Coelho, D. Abreu, L. Guedes, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)

    Objective: To compare the response of motor and non-motor symptoms (NMS) to a L-dopa challenge test  between late stage (LS) PD patients and advanced stage…
  • 2019 International Congress

    Swallowing assessment in Parkinson’s Disease using Dynamic Magnetic Resonance Imaging (dMRI)

    SG. Gudwani, PU. Upadhyay, KS. Sharma, RS. Sagar, SSK. Kumaran, RKD. Dhamija (New Delhi, India)

    Objective: To evaluate any dysphagia-signs in Parkinson’s disease (PD) with technique that is non-invasive, without-radiation-exposure and gives good soft-tissue contrast. Background: Swallowing, a basic oromotor…
  • 2019 International Congress

    Impaired lysosomal catabolism of alpha-synuclein in parkinsonian LRRK2(R1441G) mutant mouse embryonic fibroblasts

    WL. Ho, CT. Leung, HF. Liu, LF. Li, DB. Ramsden, SL. Ho (Hong Kong, Hong Kong)

    Objective: Using a unique fluorescence-based flow cytometry assay on LRRK2(R1441G) mutant mouse embryonic fibroblasts (MEFs) to elucidate whether pathogenic LRRK2 mutation affects cellular lysosomal degradation…
  • 2019 International Congress

    Concomitant brain pathologies have no major impact on clinical milestones in progressive supranuclear palsy

    M. Jecmenica-Lukic, C. Kurz, G. Respondek, O. Grau-Rivera, Y. Compta, E. Gelpi, C. Troakes, J. van Swieten, A. Giese, S. Roeber, T. Arzberger, G. Höglinger (Munich, Germany)

    Objective: To analyze the frequency and severity of co-pathologies in PSP patients and their relevance for the clinical presentation and progression in PSP. Background: The phenotypic…
  • 2019 International Congress

    Progressive Parkinsonism and Cognitive Changes: A Rare Presentation of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS)

    M. Khyat-Khoei, J. Randhawa, E. Furr-Stimming, R. Samudralwar, S. Chandra (Houston, TX, USA)

    Objective: To describe a rare manifestation of a case of CLIPPERS with video-based documentation of treatment responsiveness. Background: CLIPPERS is a rare inflammatory disease of…
  • 2019 International Congress

    Comorbid Parkinson’s disease and Myasthenia Gravis: A Case-Control Study

    K. Lafaver, D. Mohanty, C. Bodkin, M. Brown, A. Druker, J. Farmer, J. Fleisher, I. Gambhir, T. Harlow, F. Leon-Sarmiento, C. Perry, Z. Wang, A. Espay (Louisville, KY, USA)

    Objective: To evaluate the clinical features of patients with Parkinson’s Disease (PD) with versus without comorbid Myasthenia Gravis (MG). Background: The recognition of the co-occurrence…
  • 2019 International Congress

    High-throughput screening using a Drosophila model of Parkinson’s disease

    FJ. Lopez, C. Solana, E. Masia, MJ. Vicent, N. Paricio (Valencia, Spain)

    Objective: To identify potential therapeutic compounds for Parkinson’s disease (PD) treatment by combining a phenotype-based high-throughput screening assay in PD model flies with a validation…
  • 2019 International Congress

    Role of APOE ε4 status and Sex on Somatosensory Integration and Dual-Task Cost in Parkinson’s disease

    D. Martini, R. Morris, G. Mcbarron, T. Madhyastha, T. Grabowski, SC. Hu, C. Zabetian, A. Hiller, K. Chung, J. Quinn, F. Horak (Portland, OR, USA)

    Objective: To determine whether ε4 status relates to impaired somatosensory integration deficits in males more than females in people with Parkinson’s disease (PwPD). Background: Previous…
  • « Previous Page
  • 1
  • …
  • 167
  • 168
  • 169
  • 170
  • 171
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley